IBIO, INC. Adjustments to Additional Paid in Capital, Other
IBIO, INC. (IBIO) reported Adjustments to Additional Paid in Capital, Other of $21.00 thousand for the 12-month period ending 2023-06-30, per its 10-K/A filed 2024-09-24.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2024-09-24
- IBIO, INC. adjustments to additional paid in capital, other for the quarter ending 2014-06-30 was $0.00.
- IBIO, INC. adjustments to additional paid in capital, other for the quarter ending 2014-03-31 was $1.00K.
- IBIO, INC. adjustments to additional paid in capital, other for fiscal 2023 was $21.00K.
- IBIO, INC. adjustments to additional paid in capital, other for fiscal 2014 was $71.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2023-06-30 | $21.00K 10-K/A · filed 2024-09-24 | |||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-13 | $1.00K derived: sum of 2 quarters · filed 2015-10-13 | $71.00K 10-K · filed 2015-10-13 | |
| 2014-03-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15 | $71.00K 10-Q · filed 2014-05-15 | ||
| 2013-12-31 | $70.00K 10-Q · filed 2014-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |